Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.
about
MicroRNA Targeting to Modulate Tumor MicroenvironmentMiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerDysregulation of non-coding RNAs in gastric cancerMicroRNAs and triple negative breast cancerDecoding the usefulness of non-coding RNAs as breast cancer markersApoptomiRs of Breast Cancer: Basics to ClinicsMicroRNAs as potential signatures of environmental exposure or effect: a systematic reviewThe oncogenic MicroRNA Hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia responseMIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and TumorigenesisEpigenetic regulation of thyroid hormone receptor beta in renal cancer.MicroRNA-155 expression is independently predictive of outcome in chordoma.microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancersMicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.MiR-155 at the heart of oncogenic pathways.MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysisClinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentOptimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trialsMicroRNAs: novel players in cancer diagnosis and therapies.Improved repair of dermal wounds in mice lacking microRNA-155Neuronal calcium signaling pathways are associated with the development of epilepsyExosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancermiR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.MiR-101 sensitizes human nasopharyngeal carcinoma cells to radiation by targeting stathmin 1.Chaperone Hsp47 Drives Malignant Growth and Invasion by Modulating an ECM Gene NetworkDifferential expression and clinical significance of three inflammation-related microRNAs in gangliogliomasSimulated Microgravity Exerts an Age-Dependent Effect on the Differentiation of Cardiovascular Progenitors Isolated from the Human HeartThe roles of microRNAs in the regulation of tumor metastasis.Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway.MiR130b-Regulation of PPARγ Coactivator- 1α Suppresses Fat Metabolism in Goat Mammary Epithelial Cells.RBMMMDA: predicting multiple types of disease-microRNA associations.MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer.Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells.MicroRNA-155 regulates tumor myeloid-derived suppressive cellsGenome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma.High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.Double-stranded microRNA mimics can induce length- and passenger strand-dependent effects in a cell type-specific manner.Microtargeting cancer metabolism: opening new therapeutic windows based on lipid metabolism
P2860
Q26770275-91B6ABEA-9660-4E34-9F14-FE3216AFA8CEQ26775086-8EEBE4E2-4C1A-4030-B091-35D4158EF7B5Q26780293-45FFFB35-C5C0-4DC9-AC64-0DA1A8CDD6C2Q26862716-791DE527-5704-4D1F-A4D6-64C15642D4A4Q28069370-85B7D21E-5DC2-4A91-86B2-DB8E6AE9C0EDQ28072414-4BB94CC6-1D9F-4D36-B1B9-02F3F076221CQ28393390-9FC670C2-D785-41EF-8DC9-3F2BEA3C6B74Q28545001-1311C0EE-A7A5-4EC6-8E67-C386505DD17CQ29248531-AC45971B-0402-4C54-8099-CB3A2B402B17Q31161553-C28F3DA4-8D7E-4EAA-8583-C64281B91F43Q33275600-36975138-B416-4E0E-88E9-CC729EEF3E91Q33576814-29CAEAAD-8BA8-490A-8615-55251E89671FQ33607585-82E3EE74-1CF9-4644-B5E0-CDBDD44271ADQ33719285-B7878D88-E314-481F-94D0-B1F10BD57CAFQ33765619-0BB28958-F9A5-4B80-ACC8-B4D37840E28CQ33796155-2A11F77D-343B-4B0B-84BD-6B11F26E463FQ33879154-045AC1F0-6DB0-4CE8-8FAF-53AE540FC21BQ33914573-B3619259-923B-423D-9533-AB648ECCCFA4Q33954324-4A112678-7791-4EBB-A578-1FE80909F5D8Q34540827-2E0138AE-B5A8-4CDB-8693-04DA1A683FF3Q34645569-208AAFF6-B7F2-41EF-90FF-E55EB087AFFCQ34704817-7F1A44C5-AB7E-4700-A0B9-A763B5BA121BQ35051983-9E62B588-B938-4030-876B-C900BE3AF168Q35094742-52ACF4BE-9412-47E0-9FB3-AE9559B88259Q35201698-F2FC49DB-163B-407F-AD69-3CD6872392FEQ35463568-D3C1112C-1E26-451B-AA1C-843113A29BE8Q35655451-E4A933EE-E149-4C64-814A-C6A104307D53Q35687932-007D19C5-6C84-44CB-AD4C-A65290EBD5FFQ35816884-E747ABE8-D8F2-4129-A426-C5A9AB7769D9Q35833103-48701FE5-6BE0-4EAA-9E96-D311E231B0D1Q35844790-C804A626-1182-43C6-A39B-E35034E6768BQ36034189-BE14EB18-12FD-4863-B4AC-CEABD7D13AE3Q36140715-E9F49D0A-8592-4D84-8EF4-B6EDC6C5A45AQ36309555-642E1015-3647-4A27-BC7A-2AA32AF1C456Q36315338-FF6C2B3C-E741-4D8A-A941-73F3A763D878Q36363281-B4E538B3-77BD-43AD-9DEB-8AB4338415EDQ36413501-1B836B95-CE0B-42AA-B9ED-B7AA5CBC8EA4Q36414198-371639DC-C934-4AAB-8C16-2689DB0503EBQ36461905-A39E1162-0D96-41F2-8301-1BCECA1A1357Q36503853-CFC1004A-3B18-46AF-9318-01972B973E86
P2860
Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Upregulation of miRNA-155 prom ...... triple-negative breast cancer.
@en
Upregulation of miRNA-155 prom ...... triple-negative breast cancer.
@nl
type
label
Upregulation of miRNA-155 prom ...... triple-negative breast cancer.
@en
Upregulation of miRNA-155 prom ...... triple-negative breast cancer.
@nl
prefLabel
Upregulation of miRNA-155 prom ...... triple-negative breast cancer.
@en
Upregulation of miRNA-155 prom ...... triple-negative breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Upregulation of miRNA-155 prom ...... triple-negative breast cancer
@en
P2093
E J Richards
J M Lancaster
J Permuth-Wey
T A Sellers
P2860
P2888
P304
P356
10.1038/ONC.2012.636
P407
P577
2013-01-28T00:00:00Z